Table 2.
Proportion of Women With Incident Fractures in the FRISBEE Cohort and Estimated Fracture Risk by Garvan and FRAX in the Entire Cohort
| Fracture type | Incident fracture FRISBEE (n, %) | Predicted fractures at 5 years in the entire cohort (N = 3030) | |
|---|---|---|---|
| Garvan (n, %) | FRAX (n, %) | ||
| Hip | 47 (1.5) | 93 (3.1) | 46 (1.5) |
| FRAX‐MOFs | 281 (9.3) | N/A | 160 (5.3) |
| Any Garvan fractures | 356 (11.7) | 306 (10.1) | NA |
MOF = major osteoporotic fracture; N/A = not applicable.
FRAX‐MOFs = hip, wrist, proximal humerus, and clinical spine; any Garvan fractures = hip, vertebra (symptomatic), wrist, metacarpal, humerus, scapula, clavicle, distal femur, tibia/fibula, patella, pelvis, ribs, sternum, and hands and feet, excluding digits.